ENDRA Life Sciences Inc.

Historical 13F Holders

Symbol
NDRA
CUSIP
29273B302
All holders as of
Q2 2024
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 29273B302 since 12/18/2024, newest first.

Filer % of Class Filed
L1 Capital Global Opportunities Master Fund, Ltd. 13G/A Amendment 2 3.0% 11/14/2025
Event 11/14/2025
S.H.N. Financial Investments Ltd. 13G/A Amendment 1 3.0% 11/14/2025
Event 11/14/2025
Lipman John C 13G 10.0% 10/30/2025
Event 10/23/2025
ATW Partners Opportunities Management, LLC 13G
9.9% 10/28/2025
Event 10/16/2025
L1 Capital Global Opportunities Master Fund, Ltd. 13G/A Amendment 1 6.2% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2024 Q2 18 840 k $81.6k
2024 Q1 14 265 k $153k
2023 Q4 12 135 k $285k
2023 Q3 11 141 k $156k
2023 Q2 12 190 k $267k
2023 Q1 14 168 k $384k
2022 Q4 14 173 k $568k